Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04056832
Other study ID # 011
Secondary ID ETIKUI-1612576
Status Recruiting
Phase N/A
First received
Last updated
Start date April 20, 2017
Est. completion date April 20, 2020

Study information

Verified date August 2019
Source Fakultas Kedokteran Universitas Indonesia
Contact Ismail Dilawar, doctor
Phone +6281310567075
Email ismail_dilawar@yahoo.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Aortic stenosis is a commonly found heart disease, which often leads to mortality and morbidity. Valve replacement using mechanical prosthetic valve will have an expensive cost especially in the Integrated Heart Center of Cipto Mangunkusumo Hospital, Jakarta, Indonesia. In addition to the expensive cost, patients who have mechanical prosthetic valve have an increased risk of infection of the prosthetic valve and developing thrombo-embolism thus have to consume a lifelong anticoagulant therapy that increase risk of bleeding. A surgical technique using autologous pericardium is an alternative to prosthetic valve replacement, one of which is a single pericardium strip technique that uses modified autologous pericardium technique from Ozaki et al and Duran et al.

The objective of this study is to investigate the outcome of aortic valve replacement with a single pericardium strip of autologous pericardium in patients with aortic stenosis.

This study will be conducted at the Integrated Heart Center of Cipto Mangunkusumo Hospital, Jakarta, Indonesia, by using quasi experimental type time series design. Subjects are patients with aortic stenosis who are candidates for valve replacement. Inclusion criteria is having low to moderate surgical risk (EuroScore II <5). The sampling method used in this study is non-probability consecutive sampling. This study will assess the outcome of the aortic valve replacement (valve hemodynamic, left ventricular reverse remodelling, sST2, 6MWT) at 3 months and 6 months post-aortic valve replacement.

It is expected that aortic valve replacement using a single strip of autologous pericardium will have good valve hemodynamic outcome, yield left ventricular reverse remodelling, decrease sST2 level, show upgrade in 6MWT, and have shorter aortic cross clamp time so that it can be an alternative to aortic valve replacement using mechanical prosthetic valve that is less expensive and have good outcomes in patient with aortic stenosis.


Recruitment information / eligibility

Status Recruiting
Enrollment 62
Est. completion date April 20, 2020
Est. primary completion date January 20, 2020
Accepts healthy volunteers No
Gender All
Age group 10 Years and older
Eligibility Inclusion Criteria:

- Patients aged more than 10 years old

- Patients with aortic valve stenosis with an indication of aortic valve replacement having low to moderate surgical risk (EuroScore II <5)

- The patient or guardian (the research subject's parent) agrees to follow the study

Exclusion Criteria:

- Patients who have previously underwent aortic valve replacement

- Patients with aortic stenosis due to bicuspid aortic valve

- Patients with autoimmune disease

- Patients with mixed connective tissue disease

Study Design


Intervention

Procedure:
Single Strip Pericardium
The anterior pericardium is taken in accordance with the measurements made using an aortic annulus sizer or Ismail sizer. The diameter of the annulus valve is converted to circumference of the aortic valve according as a measure of the length of the pericardium. Measurement of aortic commissure height is done by measuring the distance between the lowest point of the valve attachment to the highest point on the commissure as a measure of pericardium width. The pericardium is immersed in 0.6% glutaraldehyde solution for 10 minutes, then rinsed and soaked with saline solution 3 times for 6 minutes each. After the pericardium becomes firm it is cut to be a single strip according to the length and width in the previous measurement. It is then sutured to the aortic valve annulus.
Mechanical Prosthetic Valve
Median incision is performed at the surgical site. Sternal retractor is placed at the sternum after median sternotomy being performed. Aortic valve is measured using aortic annulus sizer. Pledgeted suture is performed for the mattress. Sutures are performed to attach the mechanical prosthetic to the aortic annulus.

Locations

Country Name City State
Indonesia Cipto Mangunkusumo Central National Hospital Jakarta DKI Jakarta

Sponsors (1)

Lead Sponsor Collaborator
Fakultas Kedokteran Universitas Indonesia

Country where clinical trial is conducted

Indonesia, 

References & Publications (4)

Coffey S, Cairns BJ, Iung B. The modern epidemiology of heart valve disease. Heart. 2016 Jan;102(1):75-85. doi: 10.1136/heartjnl-2014-307020. Epub 2015 Nov 5. Review. — View Citation

d'Arcy JL, Prendergast BD, Chambers JB, Ray SG, Bridgewater B. Valvular heart disease: the next cardiac epidemic. Heart. 2011 Jan;97(2):91-3. doi: 10.1136/hrt.2010.205096. Epub 2010 Dec 13. Erratum in: Heart. 2011 Jul;97(13):1112. — View Citation

Maganti K, Rigolin VH, Sarano ME, Bonow RO. Valvular heart disease: diagnosis and management. Mayo Clin Proc. 2010 May;85(5):483-500. doi: 10.4065/mcp.2009.0706. Review. — View Citation

Osnabrugge RL, Mylotte D, Head SJ, Van Mieghem NM, Nkomo VT, LeReun CM, Bogers AJ, Piazza N, Kappetein AP. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Duration of Intensive Care Unit Stay Number of hours in the Intensive Care Unit since after the surgery until subject is transferred to hospital ward at the time of surgery
Other Duration of Ventilator Use Number of hours of breathing assisted with ventilator since intubation until extubation at the time of surgery
Primary Change in Left Ventricular End Diastolic Diameter Left Ventricular End Diastolic Diameter in mili meters assessed by Trans-thoracic Echocardiography measurement on M-mode before surgery, 3 months and 6 months after surgery
Primary Change in Left Ventricular End Systolic Diameter Left Ventricular End Systolic Diameter in mili meters assessed by Trans-thoracic Echocardiography measurement on M-mode before surgery, 3 months and 6 months after surgery
Primary Change in Ejection Fraction Percentage Ejection Fraction Percentage assessed by Trans-thoracic Echocardiography with modified Simpson's volumetric method (BiPlane measurement: apical 4 chambers and apical 2 chambers) before surgery, 3 months and 6 months after surgery
Primary Change in 6 Minute Walking Test Performance (meters) Subjects will be asked to walk for six minutes on a given track then the distance achieved will be measured in meters before surgery, 3 months and 6 months after surgery
Primary Change in 6 Minute Walking Test Performance (METs) The result of distance in meters of the six minute walking test will be converted to VO2max by the given formula:
(distance in meters x 0.03) + 3.98 = VO2max
Then the VO2max will be converted to METs by given formula:
VO2max : 3.5 = METs
before surgery, 3 months and 6 months after surgery
Primary Change in Soluble Suppression of Tumorigenicity-2 (sST2) Level Level of soluble Suppression of Tumorigenicity-2 measured in nano gram per mili Liters (ng/mL) by quantitative sandwich enzyme immunoassay technique assessed with Quantikinine Elisa before surgery, 3 months and 6 months after surgery
Secondary Coaptation Height of Aortic Valve Leaflet in mili meters Aortic Valve Coaptation height measured in mili meters by Trans-oesophageal Echocardiography on mid-oesophageal long axis view at the time of surgery
Secondary Effective Height of Aortic Valve in mili meters Effective Height of Aortic Valve measured in mili meters from Aortic annulus to the highest point of Aortic Valve coaptation by Trans-oesophageal Echocardiography in mid-oesophageal long axis view at the time of surgery
Secondary Aortic Jet Velocity Value in m/s Aortic Jet Velocity value measured in meters per second (m/s) by Color Wave Doppler on Trans-thoracic Echocardiography before surgery
Secondary Mean Trans-aortic Pressure Gradient Value in mmHg Mean Trans-aortic Pressure Gradient Value measured in mili meters Hydrargyrum (mmHg) with Bernoulli equation on Trans-thoracic Echocardiography before surgery
Secondary Aortic Stenosis Severity Aortic Stenosis Severity classified as mild, moderate, and severe based on Recommendations from European Association of Echocardiography and American Society of Echocardiography (EAE/ASE) before surgery
Secondary Aortic Regurgitation Severity Aortic Regurgitation Severity classified as mild, moderate, and severe based on Recommendations from American Society of Echocardiography before surgery
Secondary Number of Valve Replacement and/or Repair Number of valves being replaced and/or repaired at the time of surgery
Secondary Aortic Cross Clamp Time in minute The time from Aortic Cross Clamp On to Cross Clamp Off at the time of surgery
Secondary Surgery Time in minute The time from first incision to finished closing surgical wound at the time of surgery
Secondary Cardiopulmonary Bypass Time in minute The time from begin Cardiopulmonary Bypass (CPB) On to CPB Off at the time of surgery
Secondary Duration of Hospitalization Number of days of Hospitalization since admission date to discharge date at the time of surgery
See also
  Status Clinical Trial Phase
Completed NCT03186339 - Validation of the "TASQ" in Patients Undergoing SAVR or TF-TAVI
Recruiting NCT03549559 - Imaging Histone Deacetylase in the Heart N/A
Terminated NCT02854319 - REpositionable Percutaneous Replacement of NatIve StEnotic Aortic Valve Through Implantation of LOTUS EDGE Valve System N/A
Recruiting NCT05601453 - The ReTAVI Prospective Observational Registry
Withdrawn NCT05481814 - CPX in Paradoxical Low Flow Aortic Stenosis
Completed NCT02241109 - Predicting Aortic Stenosis Progression by Measuring Serum Calcification Propensity N/A
Completed NCT01700439 - Surgical Treatment of Aortic Stenosis With a Next Generation, Rapid Deployment Surgical Aortic Valve N/A
Recruiting NCT04429035 - SLOW-Slower Progress of caLcificatiOn With Vitamin K2 N/A
Completed NCT04103931 - Impact of a Patient Decision Aid for Treatment of Aortic Stenosis N/A
Completed NCT03950440 - Assessing the Incidence of Postoperative Delirium Following Aortic Valve Replacement
Active, not recruiting NCT02661451 - Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD) N/A
Completed NCT02847546 - Evaluation of the BARD® True™ Flow Valvuloplasty Perfusion Catheter for Aortic Valve Dilatation N/A
Completed NCT02758964 - Evaluation of Cerebral Thrombembolism After TAVR
Completed NCT02792452 - Clinical Value of Stress Echocardiography in Moderate Aortic Stenosis
Not yet recruiting NCT02541877 - Sizing-sTrategy of Bicuspid AoRtic Valve Stenosis With Transcatheter Self-expandable Valve Phase 3
Not yet recruiting NCT02536703 - Safety and Efficacy of Lotus Valve For TAVI In Patients With Severe Aortic Stenosis In Chinese Population Phase 3
Completed NCT02249000 - BIOVALVE - I / II Clincial Investigation N/A
Not yet recruiting NCT02221921 - Safety and Efficacy Study of MicroPort's Transcatheter Aortic Valve and Delivery System for TAVI N/A
Active, not recruiting NCT02080299 - Protection by Remote Ischemic Preconditioning During Transcatheter Aortic Valve Implantation Phase 2
Terminated NCT01939678 - Characterization and Role of Mutations in Sodium-phosphate Cotransporters in Patients With Calcific Aortic Valve Disease